Select a calendar:
Filter March Events by Event Type:
SUNMONTUEWEDTHUFRISAT
Events for March 07, 2025
-
PhD Welcome Breakfast
Fri, Mar 07, 2025 @ 08:00 AM - 10:00 AM
USC Viterbi School of Engineering, Viterbi School of Engineering Graduate Admission
Receptions & Special Events
Welcome breakfast for newly admitted Fall 2025 Viterbi PhD students
Location: Town & Gown (TGF) -
Audiences: Admitted Viterbi PhD Students
Contact: Maria Sandone
This event is open to all eligible individuals. USC Viterbi operates all of its activities consistent with the University's Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation, or any other prohibited factor. -
EiS Communications Hub - Tutoring for Engineering Ph.D. StudentsFri, Mar 07, 2025 @ 10:00 AM - 12:00 PM
Viterbi School of Engineering Student Affairs
Workshops & Infosessions
Viterbi Ph.D. students are invited to drop by the Hub for instruction on their writing and speaking tasks! All tutoring is one-on-one and conducted by Viterbi faculty.
Location: Ronald Tutor Hall of Engineering (RTH) - 222A
Audiences: Viterbi Ph.D. Students
Contact: Helen Choi
Event Link: https://sites.google.com/usc.edu/eishub/home
This event is open to all eligible individuals. USC Viterbi operates all of its activities consistent with the University's Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation, or any other prohibited factor. -
Alfred E.Mann Department of Biomedical Engineering - Seminar series
Fri, Mar 07, 2025 @ 11:00 AM - 12:00 PM
Alfred E. Mann Department of Biomedical Engineering
Conferences, Lectures, & Seminars
Speaker: Aijun Wang, Ph.D. , ChancellorâÂÂs Fellow Professor of Surgery and Biomedical Engineering, Co-Director, Center for Surgical Bioengineering, Vice Chair for Translational Research, Innovation and Entrepreneurship, Department of Surgery UC Davis School of Medicine
Talk Title: "Engineering Stem Cells and Extracellular Components for In Utero Treatment of Congenital Anomalies"
Abstract: Birth defects contribute significantly to pediatric morbidity and mortality, affecting 1 in 33 infants in the United States. As the leading cause of infant mortality, many congenital anomalies lack effective treatments or cures. Emerging prenatal interventions – such as fetal surgery, in utero stem cell therapy and genome editing – offer the potential to treat or even cure these conditions before birth. Dr. Aijun Wang Lab at UC Davis is at the forefront of fetal tissue engineering and gene editing, developing innovative translational technologies to modify the fetal environment and address congenital disorders. The Wang lab develops innovative technologies for stem cell transplantation, and integrates stem cell-derived extracellular vesicles, biomaterial scaffolds mimicking the extracellular matrix, and non-viral gene editing techniques. A major focus of the lab has been pioneering stem cell therapy for in utero treatment of spina bifida. Their team successfully manufactured clinical-grade placenta-derived mesenchymal stem cells (PMSCs) at the UC Davis GMP facility, obtained FDA investigational new drug (IND) approval, and is currently conducting the world’s first stem cell clinical trial using PMSCs for prenatal spina bifida treatment. Additionally, the Wang Lab is advancing non-viral genome editing technologies using lipid nanoparticles to genetically correct developing stem cells, offering a potential prenatal treatment for genetic disorders. To enhance stem cell targeting and function, they have applied novel integrin-based ligands identified through One-Bead One-Compound (OBOC) combinatorial technology. These groundbreaking approaches mark a transformative step in prenatal medicine, with the potential to redefine the management of congenital anomalies.
Biography: Dr. Aijun Wang received his PhD in biology from Tsinghua University, Beijing, China and completed his postdoctoral training at University of California, Berkeley Bioengineering and Berkeley Stem Cell Center. He joined University of California, Davis (UC Davis) faculty in 2012, and is currently a Chancellor's Fellow Professor of Surgery and of Biomedical Engineering. He serves as Vice Chair for Translational Research, Innovation and Entrepreneurship in the Department of Surgery, Co-Director of the Center for Surgical Bioengineering, and inaugural Dean's Fellow in Entrepreneurship at the UC Davis School of Medicine. Additionally, he is a Principal Investigator at the Institute for Pediatric Regenerative Medicine (IPRM) / Shriners Children's Pediatric Research Center, Northern California. Dr. Wang’s research focuses on developing innovative tools, technologies, and therapeutics that integrate molecular, cellular, tissue, and biomaterial engineering to drive tissue regeneration and restore function. Dr. Wang’s lab utilizes single cell spatial multi-omics to study disease mechanisms and developmental process and engineers and develops stem cell therapy/genome editing, extracellular vesicles/nanomedicine, and extracellular matrix/biomaterial scaffolds to treat a wide spectrum of congenital conditions and acquired diseases. Dr. Wang specializes in translating discoveries from bench to bedside through innovative research, translational and investigational new drug (IND)-enabling studies, current Good Manufacturing Practice (cGMP) manufacturing, and clinical trials in both human and companion animal patients. Dr. Wang has published over 180 peer-reviewed papers in top-tier journals, such as Nature Nanotechnology, Nature Communications, ACS Nano, Advanced Functional Materials, Bioactive Materials, Biomaterials, Journal of Extracellular Vesicles, Stem Cells, and Theranostics. Since joining UC Davis, Dr. Wang has served as PI, MPI or Co-PI, on numerous major extramural and intramural grants, securing over $55 million in funding from agencies such as NIH/NINDS, NIH/NIBIB, NIH/NICHD, the California Institute for Regenerative Medicine (CIRM), the Tobacco-Related Disease Research Program of California (TRDRP), Shriners Hospital for Children, and other foundations. Dr. Wang has received numerous awards, such as the UC Davis Health Dean’s Fellowship (2018), the UC Davis Chancellor's Fellowship (2020), the UC Davis Health Dean’s Team Award for Excellence in Research (2020), the UC Davis School of Medicine Cultivating Team Science Award (2022), the KidneyX Innovation award (2020), and the Sacramento Region Innovation Award (2021). In recognition of his outstanding contributions to regenerative medicine and translational bioengineering, Dr. Wang was inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows in 2024.
Host: Eunji Chung
Location: Ronald Tutor Hall of Engineering (RTH) - Room 109
Audiences: Everyone Is Invited
Contact: Carla Stanard
This event is open to all eligible individuals. USC Viterbi operates all of its activities consistent with the University's Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation, or any other prohibited factor. -
Alfred E.Mann Department of Biomedical Engineering - Seminar series
Fri, Mar 07, 2025 @ 11:00 AM - 12:00 PM
Alfred E. Mann Department of Biomedical Engineering
Conferences, Lectures, & Seminars
Speaker: Aijun Wang, Ph.D., ChancellorâÂÂs Fellow Professor of Surgery and Biomedical Engineering, Co-Director, Center for Surgical Bioengineering, Vice Chair for Translational Research, Innovation and Entrepreneurship, Department of Surgery UC Davis School of Medicine
Talk Title: Engineering Stem Cells and Extracellular Components for In Utero Treatment of Congenital Anomalies"
Abstract: Birth defects contribute significantly to pediatric morbidity and mortality, affecting 1 in 33 infants in the United States. As the leading cause of infant mortality, many congenital anomalies lack effective treatments or cures. Emerging prenatal interventions – such as fetal surgery, in utero stem cell therapy and genome editing – offer the potential to treat or even cure these conditions before birth. Dr. Aijun Wang Lab at UC Davis is at the forefront of fetal tissue engineering and gene editing, developing innovative translational technologies to modify the fetal environment and address congenital disorders. The Wang lab develops innovative technologies for stem cell transplantation, and integrates stem cell-derived extracellular vesicles, biomaterial scaffolds mimicking the extracellular matrix, and non-viral gene editing techniques. A major focus of the lab has been pioneering stem cell therapy for in utero treatment of spina bifida. Their team successfully manufactured clinical-grade placenta-derived mesenchymal stem cells (PMSCs) at the UC Davis GMP facility, obtained FDA investigational new drug (IND) approval, and is currently conducting the world’s first stem cell clinical trial using PMSCs for prenatal spina bifida treatment. Additionally, the Wang Lab is advancing non-viral genome editing technologies using lipid nanoparticles to genetically correct developing stem cells, offering a potential prenatal treatment for genetic disorders. To enhance stem cell targeting and function, they have applied novel integrin-based ligands identified through One-Bead One-Compound (OBOC) combinatorial technology. These groundbreaking approaches mark a transformative step in prenatal medicine, with the potential to redefine the management of congenital anomalies.
Biography: Dr. Aijun Wang received his PhD in biology from Tsinghua University, Beijing, China and completed his postdoctoral training at University of California, Berkeley Bioengineering and Berkeley Stem Cell Center. He joined University of California, Davis (UC Davis) faculty in 2012, and is currently a Chancellor's Fellow Professor of Surgery and of Biomedical Engineering. He serves as Vice Chair for Translational Research, Innovation and Entrepreneurship in the Department of Surgery, Co-Director of the Center for Surgical Bioengineering, and inaugural Dean's Fellow in Entrepreneurship at the UC Davis School of Medicine. Additionally, he is a Principal Investigator at the Institute for Pediatric Regenerative Medicine (IPRM) / Shriners Children's Pediatric Research Center, Northern California. Dr. Wang’s research focuses on developing innovative tools, technologies, and therapeutics that integrate molecular, cellular, tissue, and biomaterial engineering to drive tissue regeneration and restore function. Dr. Wang’s lab utilizes single cell spatial multi-omics to study disease mechanisms and developmental process and engineers and develops stem cell therapy/genome editing, extracellular vesicles/nanomedicine, and extracellular matrix/biomaterial scaffolds to treat a wide spectrum of congenital conditions and acquired diseases. Dr. Wang specializes in translating discoveries from bench to bedside through innovative research, translational and investigational new drug (IND)-enabling studies, current Good Manufacturing Practice (cGMP) manufacturing, and clinical trials in both human and companion animal patients. Dr. Wang has published over 180 peer-reviewed papers in top-tier journals, such as Nature Nanotechnology, Nature Communications, ACS Nano, Advanced Functional Materials, Bioactive Materials, Biomaterials, Journal of Extracellular Vesicles, Stem Cells, and Theranostics. Since joining UC Davis, Dr. Wang has served as PI, MPI or Co-PI, on numerous major extramural and intramural grants, securing over $55 million in funding from agencies such as NIH/NINDS, NIH/NIBIB, NIH/NICHD, the California Institute for Regenerative Medicine (CIRM), the Tobacco-Related Disease Research Program of California (TRDRP), Shriners Hospital for Children, and other foundations. Dr. Wang has received numerous awards, such as the UC Davis Health Dean’s Fellowship (2018), the UC Davis Chancellor's Fellowship (2020), the UC Davis Health Dean’s Team Award for Excellence in Research (2020), the UC Davis School of Medicine Cultivating Team Science Award (2022), the KidneyX Innovation award (2020), and the Sacramento Region Innovation Award (2021). In recognition of his outstanding contributions to regenerative medicine and translational bioengineering, Dr. Wang was inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows in 2024.
Host: Eunji Chung
Location: Ronald Tutor Hall of Engineering (RTH) - 109
Audiences: Everyone Is Invited
Contact: Carla Stanard
This event is open to all eligible individuals. USC Viterbi operates all of its activities consistent with the University's Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation, or any other prohibited factor. -
Technology for Business Leaders
Fri, Mar 07, 2025 @ 11:00 AM - 12:00 PM
Executive Education
Conferences, Lectures, & Seminars
Speaker: Dr. Bhaskar Krishnamachari, Ming Hsieh Department of Electrical and Computer Engineering
Talk Title: Technology for Business Leaders
Abstract: Technology for Business Leaders provides a comprehensive exploration of digital transformation and its impact on contemporary business landscapes. Through a series of structured modules, participants will delve into the core concepts of Digital Technologies, Industry 4.0, Innovation, and Organizational Change management. By analyzing case studies and leveraging practical frameworks, learners will develop the necessary insights and skills to drive successful digital transitions within their organizations.
Host: USC Viterbi Corporate and Professional Programs
Audiences: Everyone Is Invited
Contact: VASE Executive Education
This event is open to all eligible individuals. USC Viterbi operates all of its activities consistent with the University's Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation, or any other prohibited factor. -
CA DREAMS - Technical Seminar Series
.jpg)
Fri, Mar 07, 2025 @ 12:00 PM - 01:00 PM
Information Sciences Institute
Conferences, Lectures, & Seminars
Speaker: Umesh K. Mishra, Dean, Richard A Auhll Dean of the College of Engineering at the University of California Santa Barbara
Talk Title: A Brief History and the Promise of Gallium Nitride (GaN) Electronics; the Next Wave After GaN Photonics
Abstract: In this talk, we will recount the development of GaN electronics over its history of nearly 40 years to its widepsread deployment today in commercial and DoD systems.
Biography: Umesh K. Mishra is the Richard A Auhll Dean of the College of Engineering at the University of California Santa Barbara and the Donald W. Whittier Distinguished Professor of Electrical and Computer Engineering at UC Santa Barbara. He received his B.Tech from the Indian Institute of Technology in Kanpur, India, his M.S from Lehigh University in Bethlehem, PA., and his Ph.D. in 1984 from Cornell University in Ithaca, NY. He has supervised 81 Ph.D theses to completion with 15 of them being women and 69 of them in the field of Gallium Nitride (GaN) materials and devices. 11 of his students are members of the faculty in prestigious universities, with 5 of them being women. His students have founded/co-founded 10 companies. He co-founded the first start-up in the world to commercialize RF GaN transistors and LEDs in 1996 (Nitres) which was acquired by CREE (now Wolfspeed) in 2000. Umesh co-founded Transphorm in 2007 which was honored as a Technology Pioneer at the World Economic Forum, 2013, to commercialize GaN-on-Si transistors for power conversion. Transphorm was acquired by Renesas in 2024. He has over 1000 papers (>70,000 citations; h-index 130) and over 100 patents. Umesh received several awards including the IEEE Jun-Ichi Nishizawa Medal for his contributions to the development and commercialization of GaN electronics. He is a Fellow of the IEEE, an International Fellow of the Japanese Society of Applied Physics, Fellow of the National Academy of Inventors, a Member of the National Academy of Engineering and a Distinguished Alumnus of IIT Kanpur.
Host: Dr. Steve Crago
More Info: https://www.isi.edu/events/5356/a-brief-history-and-the-promise-of-gallium-nitride-gan-electronics-the-next-wave-after-gan-photonics/
Webcast: https://usc.zoom.us/j/97017422125?pwd=Dbrt8MNMrmBV3xalKQJcAiNsggFJjJ.1&from=addonWebCast Link: https://usc.zoom.us/j/97017422125?pwd=Dbrt8MNMrmBV3xalKQJcAiNsggFJjJ.1&from=addon
Audiences: Everyone Is Invited
Contact: Amy Kasmir
This event is open to all eligible individuals. USC Viterbi operates all of its activities consistent with the University's Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation, or any other prohibited factor.
.jpg)